Markets.com Logo

ANNX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.0987$
  • Previous Close
    2.1497$
  • 52 Week Change
    6.57$
  • Day Range
    -0.05$
  • 52 Week High/Low
    1.285$ - 7.85$
  • Dividend Per Share
    --
  • Market cap
    235 M$
  • EPS
    -0.34
  • Beta
    1.297
  • Volume
    --

About

ANNX.US represents Annexon Biosciences Inc., a clinical-stage biopharmaceutical company focused on developing a new class of medicines for chronic, progressive complement-mediated neurodegenerative diseases. Their primary therapeutic approach involves blocking C1q, the initiating molecule of the classical complement pathway, to potentially halt or slow the progression of diseases like Huntington's disease, geographic atrophy, and amyotrophic lateral sclerosis (ALS). The company's pipeline includes multiple clinical trials, with data readouts from these studies being key catalysts for the stock's performance.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Clinical Trial Results: Positive outcomes in Annexon Biosciences' clinical trials for its drug candidates typically lead to stock price increases, while negative or inconclusive results can cause a price decrease.

Regulatory Approvals: Achieving regulatory approval from bodies like the FDA for its drugs significantly boosts investor confidence and drives up the stock price. Delay or rejection can negatively impact the price.

Competition: Developments in competing treatments for the same diseases Annexon is targeting can affect the stock price. A competitor's success might pressure ANNX.US stock.

Financial Performance: Strong financial reports, showing healthy cash flow and effective management, often correlate with a higher stock price. Conversely, poor financial results can lead to a decline.

Market Sentiment: General investor sentiment towards the biotechnology sector influences ANNX.US. Overall bullishness lifts the stock, while a bearish market can suppress it.

Partnerships and Collaborations: Strategic partnerships with other pharmaceutical companies can improve Annexon's prospects and positively influence the stock price. Lack of partnerships, or termination of existing ones, can have a negative effect.

Intellectual Property: The strength and security of Annexon's patents protect its drug candidates. Challenges to or loss of IP can lower the stock price.

Management Changes: Significant changes in leadership can signal uncertainty and affect investor confidence, leading to stock price volatility. New leadership with a strong track record can inspire confidence.

Macroeconomic Factors: Economic conditions, such as interest rates and inflation, can impact investor risk appetite and influence valuations of biotechnology stocks like ANNX.US.

Analyst Ratings: Recommendations from financial analysts can influence investor perception of ANNX.US. Positive ratings can drive up the price, while negative ratings can lead to declines.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--